The Turkish Competition Authority publishes a decision on export bans in the pharmaceutical sector (Roche)

Introduction On 27 September 2018, Turkish Competition Authority (“TCA”) published its decision [1] concerning the allegations that Roche Müstahzarları A.Ş. (“Roche”) had violated articles 4 and 6 of the Law on the Protection of Competition (“Competition Act”). Within this scope, the TCA re-evaluated whether (i) Roche’s agreement with a pharmaceutical wholesaler, Co-Re-Na Ecza Deposu Dış. Tic. Ltd. Şti. (“CORENA”), which imposed an export ban on the buyer and (ii) its alleged interference with other wholesalers for interrupting their supply of goods to CORENA is in accordance with the law. This decision is crucial as it will shed some light on the TCA’s approach towards export ban clauses. As will be explained below, the TCA insisted on its previous conclusion that the export ban in the agreement

L'accès à cet article est réservé aux abonnés

Déjà abonné ? Identifiez-vous

L’accès à cet article est réservé aux abonnés.

Lire gratuitement un article

Vous pouvez lire cet article gratuitement en vous inscrivant.

 

Version PDF

Auteur

Citation

Bahadır Balkı, The Turkish Competition Authority publishes a decision on export bans in the pharmaceutical sector (Roche), 27 septembre 2018, Bulletin e-Competitions November 2018, Art. N° 88210

Visites 353

Tous les numéros

  • Latest News issue 
  • Tous les News issues
  • Latest Special issue 
  • Tous les Special issues